FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385330251> ?p ?o ?g. }

• W4385330251 endingPage "1723" @default.
• W4385330251 startingPage "1715" @default.
• W4385330251 abstract "Introduction Mental health disorders, especially depressive and anxiety disorders, are associated with substantial health-related burden. While the second-generation antidepressants are widely accepted as first-line pharmacological treatment for major depressive disorder (MDD), patient response to such treatment is variable, with more than half failing to achieve complete remission, and residual symptoms are frequently present.Areas covered Here, the pharmacodynamics of venlafaxine XR are reviewed in relation to its role as both a selective serotonin reuptake inhibitor (SSRI) and a serotonin-norepinephrine-reuptake inhibitor (SNRI), and we look at how these pharmacodynamic properties can be harnessed to guide clinical practice, asking the question ‘is it possible to develop a symptom-cluster-based approach to the treatment of MDD with comorbid anxiety utilizing venlafaxine XR?.’ Additionally, three illustrative clinical cases provide practical examples of the utility of venlafaxine-XR in real-world clinical practice. The place of venlafaxine XR in managing fatigue/low energy, a frequent residual symptom in MDD, is explored using pooled data from clinical trials of venlafaxine XR.Expert opinion Venlafaxine XR should be considered as a first-line treatment for MDD with or without comorbid anxiety, and there are clear pharmacodynamic signals supporting a symptom cluster-based treatment paradigm for venlafaxine XR." @default.
• W4385330251 created "2023-07-29" @default.
• W4385330251 creator A5007804303 @default.
• W4385330251 creator A5008331037 @default.
• W4385330251 creator A5009053470 @default.
• W4385330251 creator A5027318071 @default.
• W4385330251 creator A5051003442 @default.
• W4385330251 creator A5081927068 @default.
• W4385330251 creator A5092777424 @default.
• W4385330251 date "2023-08-07" @default.
• W4385330251 modified "2023-09-27" @default.
• W4385330251 title "Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder" @default.
• W4385330251 cites W1623415077 @default.
• W4385330251 cites W1922178820 @default.
• W4385330251 cites W1981771009 @default.
• W4385330251 cites W1983717552 @default.
• W4385330251 cites W1989007151 @default.
• W4385330251 cites W1996876492 @default.
• W4385330251 cites W2002146908 @default.
• W4385330251 cites W2005124365 @default.
• W4385330251 cites W2005693447 @default.
• W4385330251 cites W2018425549 @default.
• W4385330251 cites W2018996828 @default.
• W4385330251 cites W2037465712 @default.
• W4385330251 cites W2037824539 @default.
• W4385330251 cites W2060878519 @default.
• W4385330251 cites W2077611326 @default.
• W4385330251 cites W2082270426 @default.
• W4385330251 cites W2098062447 @default.
• W4385330251 cites W2101624688 @default.
• W4385330251 cites W2114371710 @default.
• W4385330251 cites W2115714588 @default.
• W4385330251 cites W2126095527 @default.
• W4385330251 cites W2132324173 @default.
• W4385330251 cites W2139821383 @default.
• W4385330251 cites W2144872995 @default.
• W4385330251 cites W2148760296 @default.
• W4385330251 cites W2154013799 @default.
• W4385330251 cites W2185096901 @default.
• W4385330251 cites W2288237226 @default.
• W4385330251 cites W2288912098 @default.
• W4385330251 cites W2319612864 @default.
• W4385330251 cites W2323218599 @default.
• W4385330251 cites W2478017657 @default.
• W4385330251 cites W2497083932 @default.
• W4385330251 cites W2545262119 @default.
• W4385330251 cites W2594270750 @default.
• W4385330251 cites W2989931298 @default.
• W4385330251 cites W3030352285 @default.
• W4385330251 cites W3080895307 @default.
• W4385330251 cites W3092849554 @default.
• W4385330251 cites W3145708260 @default.
• W4385330251 cites W3164176543 @default.
• W4385330251 cites W3175742532 @default.
• W4385330251 cites W3214127620 @default.
• W4385330251 cites W4200005207 @default.
• W4385330251 cites W4205900283 @default.
• W4385330251 cites W4224922097 @default.
• W4385330251 cites W4225773342 @default.
• W4385330251 cites W423316736 @default.
• W4385330251 cites W4255053419 @default.
• W4385330251 cites W4292309984 @default.
• W4385330251 cites W4297521011 @default.
• W4385330251 cites W4306404458 @default.
• W4385330251 cites W4312129775 @default.
• W4385330251 cites W4317772061 @default.
• W4385330251 cites W4319072231 @default.
• W4385330251 doi "https://doi.org/10.1080/14656566.2023.2242264" @default.
• W4385330251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37501324" @default.
• W4385330251 hasPublicationYear "2023" @default.
• W4385330251 type Work @default.
• W4385330251 citedByCount "0" @default.
• W4385330251 crossrefType "journal-article" @default.
• W4385330251 hasAuthorship W4385330251A5007804303 @default.
• W4385330251 hasAuthorship W4385330251A5008331037 @default.
• W4385330251 hasAuthorship W4385330251A5009053470 @default.
• W4385330251 hasAuthorship W4385330251A5027318071 @default.
• W4385330251 hasAuthorship W4385330251A5051003442 @default.
• W4385330251 hasAuthorship W4385330251A5081927068 @default.
• W4385330251 hasAuthorship W4385330251A5092777424 @default.
• W4385330251 hasBestOaLocation W43853302511 @default.
• W4385330251 hasConcept C111113717 @default.
• W4385330251 hasConcept C112705442 @default.
• W4385330251 hasConcept C118552586 @default.
• W4385330251 hasConcept C126322002 @default.
• W4385330251 hasConcept C15744967 @default.
• W4385330251 hasConcept C2776466888 @default.
• W4385330251 hasConcept C2779177272 @default.
• W4385330251 hasConcept C2780051608 @default.
• W4385330251 hasConcept C2780733359 @default.
• W4385330251 hasConcept C2909532165 @default.
• W4385330251 hasConcept C31487548 @default.
• W4385330251 hasConcept C558461103 @default.
• W4385330251 hasConcept C71924100 @default.
• W4385330251 hasConceptScore W4385330251C111113717 @default.
• W4385330251 hasConceptScore W4385330251C112705442 @default.
• W4385330251 hasConceptScore W4385330251C118552586 @default.
• W4385330251 hasConceptScore W4385330251C126322002 @default.

• next